Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

A Kampo formula, saikokaryukotsuboreito, improves serum testosterone levels of castrated mice and its possible mechanism.

Michihara S, Shin N, Watanabe S, Morimoto Y, Okubo T, Norimoto H.

Aging Male. 2013 Mar;16(1):17-21. doi: 10.3109/13685538.2012.755507. Epub 2013 Jan 22. Erratum in: Aging Male. 2013 Mar;16(1):21.

PMID:
23339665
2.

A herbal medicine, saikokaryukotsuboreito, improves serum testosterone levels and affects sexual behavior in old male mice.

Zang ZJ, Ji SY, Dong W, Zhang YN, Zhang EH, Bin Z.

Aging Male. 2015 Jun;18(2):106-11. doi: 10.3109/13685538.2014.963042. Epub 2014 Sep 26.

PMID:
25259618
3.

Change in cytokine levels after administration of saikokaryuukotsuboreito or testosterone in patients with symptoms of late-onset hypogonadism.

Tsujimura A, Miyagawa Y, Okuda H, Yamamoto K, Fukuhara S, Nakayama J, Takao T, Nonomura N, Okuyama A.

Aging Male. 2011 Mar;14(1):76-81. doi: 10.3109/13685538.2010.502268. Epub 2010 Aug 16.

PMID:
20712429
4.

Clinical efficacy of Japanese traditional herbal medicine (Kampo) in patients with late-onset hypogonadism.

Amano T, Imao T, Takemae K.

Aging Male. 2010 Sep;13(3):166-73. doi: 10.3109/13685530903536684.

PMID:
20143961
5.

Effects of Saikokaryukotsuboreito on Spermatogenesis and Fertility in Aging Male Mice.

Zang ZJ, Ji SY, Zhang YN, Gao Y, Zhang B.

Chin Med J (Engl). 2016 Apr 5;129(7):846-53. doi: 10.4103/0366-6999.178972.

6.

[Role of androgen in the elderly. Clinical androgen replacement therapy for late-onset hypogonadism].

Amano T.

Clin Calcium. 2013 Aug;23(8):1179-84. doi: CliCa130811791184. Review. Japanese.

PMID:
23892219
7.

Clinical trial of treatment with saikokaryukotsuboreito for eugonadal patients with late-inset hypogonadism-related symptoms.

Tsujimura A, Takada S, Matsuoka Y, Nakayama J, Takao T, Miyagawa Y, Nonomura N, Okuyama A.

Aging Male. 2008 Jun;11(2):95-9. doi: 10.1080/13685530802172529.

PMID:
18570062
8.

Hormone profiles after intramuscular injection of testosterone enanthate in patients with hypogonadism.

Nakazawa R, Baba K, Nakano M, Katabami T, Saito N, Takahashi T, Iwamoto T.

Endocr J. 2006 Jun;53(3):305-10. Epub 2006 May 19.

9.

Testosterone replacement therapy in male late onset hypogonadism: available pharmacological strategies.

Turchi P, Simi S, Pescatori ES.

J Endocrinol Invest. 2005;28(11 Suppl Proceedings):61-8. Review.

PMID:
16760628
10.
11.

[Androgen replacement therapy improves health-related quality of life in late onset hypogonadism patients].

Taniguchi H, Kawa G, Kinoshita H, Matsuda T.

Hinyokika Kiyo. 2009 Dec;55(12):741-4. Japanese.

12.

Is discontinuation of hormone replacement therapy possible for patients with late-onset hypogonadism?

Tsujimura A, Takada S, Matsuoka Y, Hirai T, Takao T, Miyagawa Y, Nonomura N, Okuyama A.

Int J Urol. 2008 Jul;15(7):625-9. doi: 10.1111/j.1442-2042.2008.02061.x. Epub 2008 May 8.

13.

Puerariae radix prevents bone loss in castrated male mice.

Wang X, Wu J, Chiba H, Yamada K, Ishimi Y.

Metabolism. 2005 Nov;54(11):1536-41.

PMID:
16253645
14.

Treatment of climacteric symptoms with herbal formulas of traditional Chinese medicine.

Pan B, Kato Y, Sengoku K, Takuma N, Niizeki N, Ishikawa M.

Gynecol Obstet Invest. 2004;57(3):144-8. Epub 2003 Dec 30.

PMID:
14707474
15.

[The efficacy of testosterone ointment (Glowmin) treatment for late-onset-hypogonadism (LOH) patients according to LOH severity].

Amano T, Imao T, Takemae K, Iwamoto T, Baba K, Yamakawa K, Nakazawa R, Yoshida K, Sugimori H, Tanaka T, Katabami T, Tanaka M.

Hinyokika Kiyo. 2007 Jan;53(1):25-9; discussion 29. Japanese.

17.

Testosterone replacement therapy by testosterone ointment relieves lower urinary tract symptoms in late onset hypogonadism patients.

Amano T, Imao T, Takemae K, Iwamoto T, Nakanome M.

Aging Male. 2010 Dec;13(4):242-6. doi: 10.3109/13685538.2010.487552. Epub 2010 Aug 26.

PMID:
20795793
18.

Late-onset hypogonadism (LOH) and androgens: validity of the measurement of free testosterone levels in the diagnostic criteria in Japan.

Iwamoto T, Yanase T, Horie H, Namiki M, Okuyama A.

Int J Urol. 2009 Feb;16(2):168-74. doi: 10.1111/j.1442-2042.2008.02203.x. Epub 2008 Nov 27. Review.

19.

Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.

Coward RM, Simhan J, Carson CC 3rd.

BJU Int. 2009 May;103(9):1179-83. doi: 10.1111/j.1464-410X.2008.08240.x. Epub 2008 Dec 23.

20.

Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review.

Mäkinen JI, Huhtaniemi I.

Gerontology. 2011;57(3):193-202. doi: 10.1159/000319635. Epub 2010 Aug 2. Review.

Supplemental Content

Support Center